pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 88 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    VP-001
    Retinitis Pigmentosa (Retinitis) PYC Therapeutics Ltd
  • Phase 2
    VVN-001
    Keratoconjunctivitis Sicca (Dry Eye) VivaVision Biotech Ltd
  • Phase 2
    VVN-461
    Ocular Inflammation VivaVision Biotech Ltd
  • Phase 2
← prev
page 3 of 3
next →
131
Pain89
Neurology1
YPP-10
Keratoconjunctivitis Sicca (Dry Eye)
Yuyu Pharma Inc
  • Phase 2
    betamethasone
    betamethasone
    Keratoconjunctivitis Sicca (Dry Eye) Surface Ophthalmics Inc
  • Phase 2
    cenegermin
    Oxervate (cenegermin-bkbj)
    Non-Arteritic Anterior Ischemic Optic Neuropathy Dompe Farmaceutici SpA
  • Phase 2
    cevaretigene ritoparvovec
    cevaretigene ritoparvovec
    Leber Congenital Amaurosis (LCA)$MGTX MeiraGTx Holdings plc
  • Phase 2
    esonadogene imvoparvovec
    esonadogene imvoparvovec [INN]
    Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Wuhan Neurophth Biological Technology Ltd
  • Phase 2
    famzeretcel
    famzeretcel [INN]
    Retinitis Pigmentosa (Retinitis) jCyte Inc
  • Phase 2
    foselutoclax
    foselutoclax [INN]
    Diabetic Macular Edema Unity Biotechnology Inc
  • Phase 2
    lonigutamab
    lonigutamab [INN]
    Graves' Ophthalmopathy$ALMS ALUMIS INC.
  • Phase 2
    lufepirsen
    Nexagon (lufepirsen [INN])
    Persistent Corneal Epithelial Defects Amber Ophthalmics Inc
  • Phase 2
    nesvategrast
    nesvategrast [INN]
    Diabetic Macular Edema OcuTerra Therapeutics Inc
  • Phase 2
    onzemipgene parvec
    onzemipgene parvec [INN]
    Dry (Atrophic) Macular Degeneration$JNJ JOHNSON & JOHNSON
  • Phase 2
    oxymetazoline
    oxymetazoline [INN]
    Ptosis Levation Pharma Ltd
  • Phase 2
    pacibekitug
    pacibekitug
    Atherosclerosis Tourmaline Bio Inc
  • Phase 2
    povidone iodine ER
    povidone iodine [USP]
    Bacterial Conjunctivitis iView Therapeutics Inc
  • Phase 2
    privosegtor
    privosegtor [INN]
    Non-Arteritic Anterior Ischemic Optic Neuropathy$OCS Oculis Holding AG
  • Phase 2
    risuteganib
    Luminate (risuteganib)
    Dry (Atrophic) Macular Degeneration Allegro Ophthalmics LLC
  • Phase 2
    rivasterat
    rivasterat [INN]
    Diabetic Macular Edema Thea Open Innovation SASU
  • Phase 2
    sepetaprost
    sepetaprost [INN]
    Ocular Hypertension Santen Pharmaceutical Co Ltd
  • Phase 2
    sozinibercept
    sozinibercept
    Diabetic Macular Edema$CKDXF Opthea Ltd
  • Phase 2
    timolol
    timolol
    Ocular Hypertension Betaliq Inc
  • Phase 2
    tivozanib
    tivozanib
    Wet (Neovascular / Exudative) Macular Degeneration Kyowa Kirin Co Ltd
  • Phase 2
    tonabersat
    Xiflam (tonabersat [INN])
    Diabetic Nephropathy Inflammx Therapeutics Inc
  • Phase 2
    urcosimod
    urcosimod
    Keratoconjunctivitis Sicca (Dry Eye)$OKYO OKYO Pharma Ltd
  • Phase 2
    voretigene neparvovec
    Luxturna (voretigene neparvovec-rzyl)
    Choroideremia F. Hoffmann-La Roche Ltd
  • Phase 2
    xelafaslatide
    xelafaslatide
    Retinal Pigment Epithelial (RPE) Detachment ONL Therapeutics Inc